Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
expansion
Pharma
IntraBio's Aqneursa scores FDA approval for rare ataxia
Aqneursa is now the first treatment indicated for a rare and prematurely fatal ataxia.
Donavyn Coffey
Sep 21, 2026 11:10am
Mucinex maker invests $600 million in US operations overhaul
Sep 16, 2026 10:30am
FDA approves transformational expansion of Ionis’ Tryngolza
Jun 25, 2026 8:13am
Antibody expert Bio X Cell debuts Beijing distribution center
Feb 11, 2025 9:42am
Sanofi plots $437M expansion in Hyderabad
Jul 17, 2024 10:58am
Incyte builds out operations in home state of Delaware
May 21, 2024 4:17pm
